These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20847408)

  • 1. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene.
    Valla J; Yaari R; Wolf AB; Kusne Y; Beach TG; Roher AE; Corneveaux JJ; Huentelman MJ; Caselli RJ; Reiman EM
    J Alzheimers Dis; 2010; 22(1):307-13. PubMed ID: 20847408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
    Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
    Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Energy Metabolism Pathways in the Posterior Cingulate in Young Adult Apolipoprotein E ɛ4 Carriers.
    Perkins M; Wolf AB; Chavira B; Shonebarger D; Meckel JP; Leung L; Ballina L; Ly S; Saini A; Jones TB; Vallejo J; Jentarra G; Valla J
    J Alzheimers Dis; 2016 Apr; 53(1):95-106. PubMed ID: 27128370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.
    Reiman EM; Chen K; Alexander GE; Caselli RJ; Bandy D; Osborne D; Saunders AM; Hardy J
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):284-9. PubMed ID: 14688411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study.
    Dean DC; Jerskey BA; Chen K; Protas H; Thiyyagura P; Roontiva A; O'Muircheartaigh J; Dirks H; Waskiewicz N; Lehman K; Siniard AL; Turk MN; Hua X; Madsen SK; Thompson PM; Fleisher AS; Huentelman MJ; Deoni SC; Reiman EM
    JAMA Neurol; 2014 Jan; 71(1):11-22. PubMed ID: 24276092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations.
    Tamashiro-Duran JH; Squarzoni P; de Souza Duran FL; Curiati PK; Vallada HP; Buchpiguel CA; Lotufo PA; Wajngarten M; Menezes PR; Scazufca M; de Toledo Ferraz Alves TC; Busatto GF
    Age (Dordr); 2013 Jun; 35(3):777-92. PubMed ID: 22544617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration.
    Valla J; Berndt JD; Gonzalez-Lima F
    J Neurosci; 2001 Jul; 21(13):4923-30. PubMed ID: 11425920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome.
    D'Souza H; Mason L; Mok KY; Startin CM; Hamburg S; Hithersay R; Baksh RA; Hardy J; Strydom A; Thomas MSC;
    JAMA Netw Open; 2020 Sep; 3(9):e2018221. PubMed ID: 32986108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
    Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
    Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.
    Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J
    Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients.
    Wilkins HM; Koppel SJ; Bothwell R; Mahnken J; Burns JM; Swerdlow RH
    Redox Biol; 2017 Aug; 12():828-832. PubMed ID: 28448944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.
    Pievani M; Rasser PE; Galluzzi S; Benussi L; Ghidoni R; Sabattoli F; Bonetti M; Binetti G; Thompson PM; Frisoni GB
    Neuroimage; 2009 May; 45(4):1090-8. PubMed ID: 19349226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele).
    Scarmeas N; Habeck C; Anderson KE; Hilton J; Devanand DP; Pelton GH; Tabert MH; Flynn J; Park A; Ciappa A; Tycko B; Stern Y
    Am J Geriatr Psychiatry; 2004; 12(6):596-605. PubMed ID: 15545327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
    Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition memory is associated with altered resting-state functional connectivity in people at genetic risk for Alzheimer's disease.
    Matura S; Prvulovic D; Butz M; Hartmann D; Sepanski B; Linnemann K; Oertel-Knöchel V; Karakaya T; Fußer F; Pantel J; van de Ven V
    Eur J Neurosci; 2014 Oct; 40(7):3128-35. PubMed ID: 24989884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased posterior default mode network activity and structural connectivity in young adult APOE-ε4 carriers: a multimodal imaging investigation.
    Hodgetts CJ; Shine JP; Williams H; Postans M; Sims R; Williams J; Lawrence AD; Graham KS
    Neurobiol Aging; 2019 Jan; 73():82-91. PubMed ID: 30339963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease.
    Tiraboschi P; Hansen LA; Masliah E; Alford M; Thal LJ; Corey-Bloom J
    Neurology; 2004 Jun; 62(11):1977-83. PubMed ID: 15184600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
    Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
    J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.